CAPR Jumps on Cantor Upgrade & Deramiocel Clarity (notreload.xyz)
Analyst upgrade sends Capricor shares higher after company outlines BLA amendment path for deramiocel focused on upper-limb function.
Cantor Fitzgerald upgrades $CAPR to Overweight and raises target to $28 after Deramiocel BLA update. Stock surges over 110% on regulatory clarity. notreload.xyz/xy/capr-jump...
